Synthesis, Aggregation, and Chiroptical Properties of Chiral, Amphiphilic Dendrimers
作者:Matthew J. Laufersweiler、Jason M. Rohde、Jean-Louis Chaumette、Dominique Sarazin、Jon R. Parquette
DOI:10.1021/jo010423z
日期:2001.9.1
structure of the dendrimers collapses in water, resulting in an increased steric effect upon the centralcore that is manifested by lower optical rotatory power. However, contributions to the chiroptical properties from the dendron branch segments were not evident in water or organic media, suggesting that chiral substructures were not developing in the branch segments of the dendrimers. Multiangle light
Synthesis of dendrimers containing 2,5-anhydro-d-mannitol as a chiral, tetrafunctional central core with C2 symmetry
作者:Jason M. Rohde、Jon R. Parquette
DOI:10.1016/s0040-4039(98)02109-1
日期:1998.12
The synthesis of first through third generation dendrimers containing a chiral, tetrafunctional core and allyl ester termini is described. The molar rotations of the dendrimers were observed to become less negative with increasing generation; however, the rotations of the dendrimers were more negative than the starting centralcore.
Fructose analogs and their combinations as anti-cancer agents
申请人:Jia Wei
公开号:US10441564B2
公开(公告)日:2019-10-15
The present invention provides a fructose analogue and a composition thereof which can be used for cancer treatment, has a targeting effect and has little effect on normal cells, particularly when used in the treatment of acute myeloid leukemia (‘AML’) and pancreatic cancer and other types of cancer having similar metabolic characteristics. In the present invention, the fructose analog is selected from the group consisting of 2,5-anhydro-D-mannitol and the 2,5-anhydro-D-mannitol derivative substituted at the 1-position or 6-position by an amino group, an alkyl group or an aryl group, anhydro-D-mannitol tetraacetate and 2,5-anhydroglucitol and the like. The fructose analogs of the present invention can be used to prepare and treat cancer drugs and can be prepared as injectable preparations or oral preparations. The fructose analogues of the present invention can be used in combination with conventional anticancer drugs when used in the preparation of a medicament for the treatment of cancer. The fructose analogs of the present invention can be used in combination with glucose analogues in the treatment of cancer or organ fibrosis.